DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

2.13 0.04 (1.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ATRS $2.13 1.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.09
Previous Close $2.09
Daily Range $2.07 - $2.15
52-Week Range $1.87 - $5.15
Market Cap $277.9M
P/E Ratio -9.09
Dividend (Yield) $0.00 (0.0%)
Volume 1,225,063
Average Daily Volume 1,293,876
Current FY EPS -$0.25




Healthcare Information Services

Antares Pharma, Inc. (ATRS) Description

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website:

News & Commentary

3 Stocks Crushed by the Market This Week

Find out which health-care stocks got beaten down the most by the market over the past few days.

Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2014 Results - Earnings Call Transcript

Antares: Uncertainty Creates An Exceptional Buying Opportunity

Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape

Why Antares Pharma Inc. Shares Dove

Antares shares go off track following the resignation of its CEO. Find out if this is something investors should be genuinely concerned about or if it's a short-term event.

Otrexup Sales Trajectory Points To First Profitable Quarter For Antares Pharma In 2015

Is Antares Pharma A Short-Squeeze Candidate?

Antares Pharma's (ATRS) CEO Paul Wotton on Q1 2014 Results - Earnings Call Transcript

Antares Pharma Announces Additional Patent Coverage for OTREXUP

Stocks Hitting 52-Week Lows

See More ATRS News...

ATRS's Top Competitors

ATRS $2.13 (1.91%)
Current stock: ATRS
$0.00 (0.00%)
Current stock:
MDT $63.12 (-0.38%)
Current stock: MDT
COV $86.70 (-0.44%)
Current stock: COV